Link to this page
Medical Subject Headings
| Preferred Name | Etanercept | |
| Synonyms |
Etanercept-szzs Fusion Protein, TNFR-Fc TNFR Fc Fusion Protein Enbrel TNF Receptor Type II-IgG Fusion Protein Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein TNTR-Fc TNR-001 TNR001 TNF Receptor Type II IgG Fusion Protein Erelzi Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein TNT Receptor Fusion Protein TNR 001 TNFR-Fc Fusion Protein |
|
| Definitions |
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000068800 |
|
| altLabel |
Etanercept-szzs Fusion Protein, TNFR-Fc TNFR Fc Fusion Protein Enbrel TNF Receptor Type II-IgG Fusion Protein Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein TNTR-Fc TNR-001 TNR001 TNF Receptor Type II IgG Fusion Protein Erelzi Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein TNT Receptor Fusion Protein TNR 001 TNFR-Fc Fusion Protein
|
|
| AQL |
AA AD AE BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C4704668 C0717758 C0539397 C0720193 C4291381 C0539395 C0539396
|
|
| DC |
1
|
|
| definition |
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
|
|
| DX |
20160101
|
|
| HN |
2016 (1997)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
185243-69-0 OP401G7OJC 0
|
|
| isa |
http://purl.bioontology.org/ontology/MESH/D000894 http://purl.bioontology.org/ontology/MESH/D005765 |
|
| LT |
TRD
|
|
| Machine permutation |
2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015
|
|
| Mapped from | ||
| MDA |
20150709
|
|
| MMR |
20171214
|
|
| MN |
D12.644.541.500.697.624 D12.776.543.750.705.852.760.232 D12.776.124.486.485.680.697.624 D12.776.377.715.548.680.660.624 D12.776.377.715.548.538.500.624 D12.776.124.790.651.538.500.624 D12.776.124.486.485.538.500.624 D12.776.124.790.651.680.660.624
|
|
| notation |
D000068800
|
|
| PA |
D000894 D018501 D007166 D005765
|
|
| prefLabel |
Etanercept
|
|
| RR |
185243-69-0
|
|
| TERMUI |
T000877314 T403900 T000877313 T000877315 T403899 T000877316 T403898 T000877312 T000934811 T000934810 T306739
|
|
| TH |
NLM (1997) US NL NLM (1999) CA NLM (2019) ES USAN (19XX) INN (19XX) DE FDA SRS (2015) BAN (19XX)
|
|
| tui |
T116 T129 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |